August 4, 2026

Agios Pharmaceuticals (AGIO) Stock Analysis: High Potential Upside in the Biotech Sector

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a prominent name in the biotechnology sector, offers a compelling investment proposition with its innovative focus on cellular metabolism. With a market capitalization of $1.82..

Artivion, Inc. (AORT) Stock Analysis: Exploring a 52.89% Potential Upside in the Medical Device Sector

Artivion, Inc. (NASDAQ: AORT), a prominent player in the healthcare sector specializing in medical devices, is capturing investor attention due to its notable potential upside. With a market capitalization of..

Concentra Group Holdings Parent (CON) Stock Analysis: Robust Growth and Strong Buy Ratings Fuel Investor Optimism

Concentra Group Holdings Parent, Inc. (CON), a key player in the healthcare sector, operates at the intersection of medical care facilities and occupational health services in the United States. With..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Biotechnology Innovator with 51% Potential Upside

Celldex Therapeutics, Inc. (NASDAQ: CLDX) is making waves in the biotechnology sector, capturing the attention of investors with its promising therapeutic pipeline and robust analyst ratings. Headquartered in Hampton, New..

PACS Group, Inc. (PACS) Stock Analysis: Healthcare Giant with 18.35% Upside Potential

PACS Group, Inc. (PACS) stands out as a formidable player in the healthcare sector, specifically within the medical care facilities industry. With a robust market capitalization of $7.04 billion, PACS..

Vera Therapeutics, Inc. (VERA) Stock Analysis: A Biotech with 153% Potential Upside

Vera Therapeutics, Inc. (NASDAQ: VERA) is gaining attention from investors with its impressive potential upside of 153.76%, according to analyst ratings. This clinical-stage biotechnology company, headquartered in Brisbane, California, is..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: A Biotech Giant with 29% Upside Potential

Scholar Rock Holding Corporation (NASDAQ: SRRK), a cutting-edge biopharmaceutical firm, is capturing significant attention in the healthcare sector. With a market capitalization of $5.49 billion, this Cambridge, Massachusetts-based company is..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: A Promising 29.99% Upside in Biotech Innovation

Investors eyeing opportunities in the biotechnology sector should pay close attention to Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a Canada-based company operating at the cutting edge of neurological and psychiatric therapeutics...

Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: A Stable Outlook Amidst Consistent Valuation

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) presents an intriguing opportunity for investors navigating the biotechnology sector, known for its high-risk, high-reward dynamics. With a market capitalization of $3.85 billion, this Florida-based..

Janux Therapeutics, Inc. (JANX) Stock Analysis: A Biotech Gamble with 142% Potential Upside

Janux Therapeutics, Inc. (NASDAQ: JANX) is making waves in the biotechnology sector, offering investors a tantalizing opportunity with a potential upside of over 142%. This clinical-stage biopharmaceutical company, headquartered in..

Mesoblast Limited (MESO) Stock Analysis: Exploring a 141.88% Potential Upside for Biotech Investors

Mesoblast Limited (MESO), an Australian biotechnology firm, is stirring interest among investors with its promising pipeline and substantial potential upside. With a market capitalization of $1.88 billion, Mesoblast stands out..

Denali Therapeutics Inc. (DNLI) Stock Analysis: Investors Eye 48% Potential Upside Amid Strong Buy Ratings

Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical leader specializing in neurodegenerative and lysosomal storage diseases, stands out in the biotechnology sector with a market cap of $3.67 billion. As the..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Exploring a 14.61% Potential Upside in the Healthcare Sector

LeMaitre Vascular, Inc. (NASDAQ: LMAT), headquartered in Burlington, Massachusetts, stands as a noteworthy player in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Potential Upside of 116.78% Amid Promising Clinical Trials

Structure Therapeutics Inc. (NASDAQ: GPCR) is a name that has been increasingly capturing investor attention, and for good reason. With its market capitalization hitting $3.44 billion, this clinical-stage biopharmaceutical company..

Kestra Medical Technologies (KMTS) Stock Analysis: A 25% Upside Potential in the Medical Device Sector

Kestra Medical Technologies, Ltd. (NASDAQ: KMTS), a pioneering player in the medical instruments and supplies sector, is increasingly capturing investor attention with its innovative solutions in cardiovascular health. Based in..

QuidelOrtho Corporation (QDEL) Stock Analysis: 20.46% Potential Upside Amidst Market Volatility

QuidelOrtho Corporation (NASDAQ: QDEL) stands as a prominent player in the healthcare sector, specifically within the medical devices industry. Headquartered in San Diego, California, the company has carved a niche..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Exploring the 75% Potential Upside for Investors

CRISPR Therapeutics AG (NASDAQ: CRSP), a pioneering gene-editing biotechnology firm based in Switzerland, continues to capture the attention of investors with its groundbreaking CRISPR/Cas9 technology. With a market capitalization of..

Ascentage Pharma Group Internat (AAPG) Stock Analysis: A Biotech Powerhouse with a Potential Upside of 182.98%

Ascentage Pharma Group International (AAPG), a clinical-stage biotechnology company based in Suzhou, China, is making waves in the healthcare sector. Specializing in developing cutting-edge therapies for cancer, chronic hepatitis B..

NewAmsterdam Pharma (NAMS) Stock Analysis: Exploring an 86.77% Upside Potential

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a pioneering name in the biotechnology sector, is capturing investor attention with its promising pipeline and substantial upside potential. Based in Naarden, Netherlands, this..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Exploring a 15.17% Upside Potential

Guardian Pharmacy Services, Inc. (NASDAQ: GRDN) is making waves in the healthcare sector, specifically within the medical care facilities industry. With its strategic focus on providing technology-enabled services to long-term..

Search

Funds

August 4, 2026

Search

Funds

August 4, 2026

FTSE 100

Funds